ELTXElicio Therapeutics Inc. Common Stock
3.040USD-2.88%Mkt Cap: 79.90M $P/E: —3d ago
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap79.90M $
Enterprise Value71.48M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.57M $
Revenue/Share—
Last Price3.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.42
PEG—
EV/EBITDA-1.89
EV/Revenue—
P/S—
P/B8.49
EPS (TTM)-2.12
EPS (Forward)-2.17
52W Range
2.6603% of range16.00
52W High16.00 USD
52W Low2.660 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-2418.77%
ROA-153.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.95M $
CapEx (TTM)16.00K $
FCF Margin—
FCF Yield-27.93%
Net Debt-9.33M $
Net Debt/EBITDA0.25
Balance Sheet
Debt/Equity8.87
Current Ratio2.77
Quick Ratio2.55
Book Value/Sh0.3620 USD
Cash/Share0.8930 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 2, 2023
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.50 USD
Upside (mean)+442.8%
Target Range10.00 USD – 23.00 USD
$10.00+442.8% to mean$23.00
# Analysts2
Ownership
Shares Out.26.28M
Float19.19M
Insiders26.97%
Institutions17.00%
Short Interest
Short Ratio1.8d
Short % Float8.58%
Short % Out.6.65%
Shares Short1.75M
Short (prev mo.)1.73M
Technical
SMA 504.006 (-24.1%)
SMA 2008.364 (-63.7%)
Beta1.88
S&P 52W Chg18.16%
Avg Vol (30d)373.16K
Avg Vol (10d)229.93K
Technical Indicators
RSI (14)40.5
MACD-0.3253
MACD Signal-0.4639
MACD Hist.+0.1386
BB Upper3.272 USD
BB Middle3.043 USD
BB Lower2.814 USD
BB Width15.05%
ATR (14)0.3024 USD
Vol Ratio (20d)1.01x